期刊
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
卷 17, 期 3, 页码 154-161出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00002093-200307000-00007
关键词
MRI; hippocampus; Alzheimer's disease
资金
- NIA NIH HHS [AG00949, AG08702] Funding Source: Medline
As we enter the pharmacological era for the treatment of Alzheimer disease (AD), there is a growing urgency to diagnosis AD as early as possible. The ability to visualize the living brain with imaging techniques holds great promise in detecting the first lesions caused by AD and, because mapping the course of the disease over time is important for testing drug efficacy, imaging is potentially useful in drug development. In the last few years, we have been exploring imaging approaches designed to map AD's effect on the living brain. Here, these attempts will be reviewed, highlighting the advantages but also the potential pitfalls of imaging a dysfunctional brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据